TOKYO/NEW YORK -- An advisory panel under the U.S. Food and Drug Administration on Friday paved the way for the full approval of lecanemab, an Alzheim

Related Keywords

United States ,Tokyo ,Japan ,Japanese ,American ,Kosaku Mimura ,Drug Administration On ,Drug Administration ,Accelerated Approval ,Eisai Biogen ,Alzheimer S ,Drug ,Backed ,Full ,Us ,Approval ,